-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
BioNexus Gene Lab Corp quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2024.
- BioNexus Gene Lab Corp Operating Margin for the quarter ending September 30, 2024 was -9.72 %, a 66.2% increase year-over-year.
- BioNexus Gene Lab Corp annual Operating Margin for 2023 was -26.5 %, a 896% decline from 2022.
- BioNexus Gene Lab Corp annual Operating Margin for 2022 was -2.66 %, a 134% decline from 2021.
- BioNexus Gene Lab Corp annual Operating Margin for 2021 was 7.9 %, a 29.3% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)